bilaterals.org logo
bilaterals.org logo

intellectual property


Vietnam proposes amendments to stalled TPP trade deal at Sydney talks: sources
Officials from 11 of the 12 countries that committed to the Trans-Pacific Partnership (TPP) trade deal are meeting in Sydney for talks to re-energize the stalled agreement and discuss amendmends to the pact following the withdrawal of the US.
Health community’s concerns re TPP11 proposed next steps
Stronger intellectual property protection would benefit the US in return for no concessions, civil society groups tell TPP11 Ministers
Internet freedom and public interest groups concerns re TPP11 proposed next steps
Stronger intellectual property protection does not benefit the TPP11 but would benefit the US in return for no concessions by the USA, a civil society letter to ministers asserts
Pharmaceutical prices, intellectual property rights emerge as key issues in KORUS FTA discussions
Through the KORUS revision, the US is openly seeking to bridge its trade deficit with Korea by renegotiating specific terms for individual product categories.
Neelam Deo on EU-India’s perplexing relationship: Trade, Europe’s hypocrisy and China concern
Former diplomat says the EU’s insistence on opening up on wine imports from France and automobile imports from Germany have held up the EU-India FTA negotiations.
Big pharma, IP wars and profit over people
At RCEP negotiations held in India, intellectual property rights issues in medicine remain contentious
NAFTA could replay TPP biologics debate
A battle over the length of data protection for biologic medicine appears to be shaping up in the NAFTA negotiations in a replay of an issue that helped block the Trans-Pacific Partnership from becoming law.
Business groups to the administration: Keep ISDS in NAFTA
More than 100 U.S. business groups and associations are pushing the Trump administration to not only preserve investor-state dispute settlement and related provisions in an updated NAFTA agreement but to also strengthen them to further protect intellectual property and interests.
Interview with Loon Gangte
Loon Gangte is an Indian activist living with HIV and hepatitis C, founder of the Delhi Network of Positive People.
US dairy ramps up fight against EU food name protection
The U.S. dairy sector is fighting harder than ever on several fronts to halt the European Union’s global efforts to block cheese producers in other countries from using names like Roquefort, Asiago and Gorgonzola on the products they export.
Medicines in India likely to be costlier due to RCEP trade pact
However, the key issues holding the final text of these negotiations don’t seem to be getting resolved.
New Zealand negotiator at Asia trade pact talks says countries should analyse TRIPS-Plus
The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIPS-plus scenario.
RCEP IP chapter: A serious threat to access to knowledge/cultural goods?
RCEP stands to adversely affect nearly half of the world’s population on areas like access to knowledge and access to medicines. We would like to highlight five issues related to access to knowledge/cultural goods, based on the leaked IP chapter.
Greeks fear they will lose their ‘white gold’ with CETA
Farmers in Greece are concerned about the fate of feta cheese in EU trade agreements with third countries after the EU failed to fully protect the iconic product in the CETA free trade deal with Canada.
ASEAN Parliamentarians call for a focus on rights in regional trade talks
Officials from ASEAN member states and other countries meeting in India this week for negotiations on the Regional Comprehensive Economic Partnership (RCEP) should take steps to ensure that the trade deal safeguards human rights, Southeast Asian lawmakers said today.
Trading health through IPR, patents
Trade agreements between countries have a perceivable impact on access to medicines as a result of changes in patent and other national laws in different countries.
Canada blinks in face of US/Pharma pressure
The cool reasoning of the Canadian Supreme Court does not acknowledge or reference “external” pressures or the Eli Lilly v. Canada ISDS case. However, courts do not decide cases in a vacuum. This case seems to have been decided in a pressure cooker.
More trouble for Canada-EU trade deal, as drug changes delay implementation
Goal of implementing most of CETA this summer slips farther from reach.
Chamber of Commerce calls for stronger IP under NAFTA
The US Chamber of Commerce, a federation representing more than three million businesses, has called for stronger IP provisions in the renegotiation of the North American Free Trade Agreement.
NAFTA’S Chapter 19 a potential big issue
Canada and Mexico should push very hard to preserve Chapter 19 of the original NAFTA agreement, which created a mechanism to resolve disputes over anti-dumping and countervailing duty measures, a former Mexican official said.